Case number 1:18-cv-01079
Adare Pharmaceuticals, Inc. et al v. Inventia Healthcare Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 44 | Patent/Trademark Report to Commissioner (1) |
| Jul 9, 2020 | 1 | Complaint (20) |
| Mar 18, 2019 | 44 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,399,025 B2; US 9,375,410 B2. (Attachments: # (1) Stipulation of Dismissal)(ceg) |
| Mar 18, 2019 | 44 | Stipulation of Dismissal (2) |
| Mar 18, 2019 | 43 | SO ORDERED (2) Docket Text: SO ORDERED, D.I. [42] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Mitchell S. Goldberg on 3/18/2019. (ceg) |
| Mar 14, 2019 | 42 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Morrison, Susan) |
| Feb 28, 2019 | 41 | SO ORDERED (3) Docket Text: SO ORDERED, D.I. [40] Stipulation to Extend Various Deadlines in Scheduling Order. Signed by Judge Mitchell S. Goldberg on 2/28/2019. (ceg) |
| Feb 26, 2019 | 40 | Stipulation (3) Docket Text: STIPULATION extend various deadlines in scheduling order by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Morrison, Susan) |
| Jan 31, 2019 | 39 | Order (1) Docket Text: ORDER: Trial is scheduled to commence on August 10, 2020, a pre-trial conference is scheduled for 10:00 a.m., Tuesday June 9, 2020, in Courtroom 4B at the James A. Byrne Federal Courthouse, 601 Market Street, Philadelphia, Pennsylvania. Signed by Judge Mitchell S. Goldberg on 1/31/2019. (ceg) |
| Jan 22, 2019 | 38 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER approving D.I. [37] and to extend various deadlines. Signed by Judge Mitchell S. Goldberg on 1/22/2019. (nmg) |
| Jan 18, 2019 | 37 | Stipulation (3) Docket Text: Joint STIPULATION to extend various deadlines by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Morrison, Susan) |
| Jan 18, 2019 | 36 | Redacted Document (3) Docket Text: REDACTED VERSION of [35] Stipulation to extend various deadlines by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Morrison, Susan) |
| Dec 20, 2018 | 34 | Scheduling Order (9) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 6/7/2019. Amended Pleadings due by 6/7/2019. Fact Discovery completed by 9/27/2019. Opening Expert Reports due by 10/18/2019. Rebuttal Expert Reports due by 11/22/2019. Expert Discovery due by 2/28/2020. Claim Construction Opening Brief due by 6/7/2019. Claim Construction Answering Brief due by 6/28/2019. A 5-day Bench Trial is set for 8/10/2020 at 09:30 AM before Judge Mitchell S. Goldberg.(See Order for additional deadlines). Signed by Judge Mitchell S. Goldberg on 12/19/2018. (nmg) |
| Dec 6, 2018 | 33 | Proposed Order (9) Docket Text: PROPOSED ORDER Scheduling Order by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Morrison, Susan) |
| Dec 3, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Rule 16 Scheduling Conference held on 12/3/2018. (ceg) |
| Nov 30, 2018 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Supplemental Initial Disclosures filed by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Del Dotto, Kelly) |
| Nov 29, 2018 | 31 | Order (1) Docket Text: ORDER: The scheduling conference scheduled for Monday, December 3, 2018 at 2:00 p.m. will be held via telephone. Counsel for Plaintiffs shall initiate the telephone conference. Signed by Judge Mitchell S. Goldberg on 11/29/2018. (ceg) |
| Nov 28, 2018 | 30 | Proposed Order (9) Docket Text: PROPOSED ORDER Scheduling Order by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Morrison, Susan) |
| Nov 14, 2018 | 29 | SO ORDERED (2) Docket Text: SO ORDERED, [27] Stipulation dismissing Defendant's counterclaims Nos. 5-16. Signed by Judge Mitchell S. Goldberg on 11/14/2018. (ceg) |
| Nov 13, 2018 | 28 | Answer to Counterclaim (21) Docket Text: ANSWER to [17] Answer to Complaint, Counterclaim Plaintiffs' Response to Defendant's Counterclaims by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Morrison, Susan) |
| Nov 12, 2018 | 27 | Stipulation (2) Docket Text: STIPULATION dismissing Defendant's counterclaims Nos. 5-16 by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Morrison, Susan) |
| Nov 5, 2018 | 26 | Order (2) Docket Text: ORDER approving D.I. [23] STIPULATION to extend time to respond to Defendant's Counterclaims. Signed by Judge Mitchell S. Goldberg on 11/5/2018. (nmg) |
| Nov 5, 2018 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures filed by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Del Dotto, Kelly) |
| Oct 31, 2018 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Inventia Healthcare Limited's First Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Inventia Healthcare Limited.(Gattuso, Dominick) |
| Oct 29, 2018 | 23 | Stipulation (2) Docket Text: STIPULATION extend time to respond to Defendant's Counterclaims re [17] Answer to Complaint, Counterclaim by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Morrison, Susan) |
| Oct 23, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney William A. Rakoczy,Rachel P. Waldron,Christopher P. Galligan for Inventia Healthcare Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Oct 17, 2018 | 22 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Scheduling Conference: An in-person Scheduling Conference is set for 12/3/2018 at 02:00 PM before Judge Mitchell S. Goldberg at the James A. Byrne U.S. Courthouse, 601 Market Street, Philadelphia, PA, Room 7614. If the parties have no issues to discuss at the scheduling conference other than dates, they may request a telephonic scheduling conference. At least 48 hours before the scheduling conference, counsel shall submit a proposed Scheduling Order with the contents permitted and required under Fed. R. Civ. P. 16(b)(3). Signed by Judge Mitchell S. Goldberg on 10/17/2018. (SEE ORDER FOR FURTHER DETAILS) (crb) |
| Oct 16, 2018 | 21 | Order (2) Docket Text: ORDER Approving D.I. [20] STIPULATION to Extend Time for Plaintiffs to Respond to Defendant's Counterclaims filed by Adare Pharmaceuticals, Inc. Signed by Judge Mitchell S. Goldberg on 10/16/2018. (nmg) |
| Oct 12, 2018 | 20 | Stipulation (2) Docket Text: STIPULATION Extend Time for Plaintiffs to Respond to Defendant's Counterclaims by Adare Pharmaceuticals, Inc.. (Morrison, Susan) |
| Sep 25, 2018 | 19 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Inventia Healthcare Limited. (Gattuso, Dominick) |
| Sep 24, 2018 | 18 | Patent/Trademark Report (Part 2) (1) |
| Sep 24, 2018 | 18 | Patent/Trademark Report to Commissioner (1) |
| Sep 24, 2018 | 17 | Exhibit 1 - 6 (95) |
| Sep 24, 2018 | 17 | Answer to Complaint (42) |
| Sep 24, 2018 | 16 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER granting [15] Motion to Appear Pro Hac Vice Appearance of Attorney William A. Rakoczy, Rachel Pernic Waldron and Christopher P. Galligan. Signed by Judge Mitchell S. Goldberg on 9/24/2018. (nmg) |
| Sep 24, 2018 | 15 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Rachel Pernic Waldron and Christopher P. Galligan - filed by Inventia Healthcare Limited. (Gattuso, Dominick) |
| Sep 24, 2018 | 18 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,387,793 B2 ;US 7,544,372 B2 ;US 7,790,199 B2 ;US 7,820,203 B2 ;US 7,829,121 B2 ;US 8,877,245 B2 . (Attachments: # (1) Patent/Trademark Report (Part 2))(Gattuso, Dominick) |
| Sep 24, 2018 | 17 | Main Document (42) Docket Text: ANSWER to [1] Complaint, with Jury Demand , COUNTERCLAIM against Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH by Inventia Healthcare Limited. (Attachments: # (1) Exhibit 1 - 6)(Gattuso, Dominick) |
| Sep 4, 2018 | 14 | SO ORDERED (2) Docket Text: SO ORDERED, [13] Stipulation and Order to Reflect Name Change. Signed by Judge Mitchell S. Goldberg on 9/4/2018. (ceg) |
| Aug 31, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 30, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 24, 2018 | 13 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order To Reflect Name Change by Inventia Healthcare Private Limited. (Nelson, Aaron) |
| Aug 24, 2018 | 12 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Aaron M. Nelson on behalf of Inventia Healthcare Private Limited (Nelson, Aaron) |
| Aug 24, 2018 | 11 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Dominick T. Gattuso on behalf of Inventia Healthcare Private Limited (Gattuso, Dominick) |
| Aug 23, 2018 | 10 | SO ORDERED (1) Docket Text: SO ORDERED, [9] Motion for Pro Hac Vice Appearance of Attorney John R. Lane and Jonathan E. Singer. Signed by Judge Mitchell S. Goldberg on 8/23/2018. (ceg) |
| Aug 22, 2018 | 9 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney John R. Lane and Jonathan E. Singer - filed by Adare Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Del Dotto, Kelly) |
| Aug 15, 2018 | 8 | Letter (1) Docket Text: Letter to Counsel from Judge Goldberg regarding Delaware Case Assignments. (gvw) |
| Aug 1, 2018 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Teva Pharmaceuticals International GmbH, Adare Pharmaceuticals, Inc.: For Inventia Healthcare Private Limited waiver sent on 7/24/2018, answer due 10/22/2018. (Morrison, Susan) |
| Jul 25, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania (in lieu of Vacant Judgeship). Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb) |
| Jul 23, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Inventia Healthcare Private Limited on 7/23/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Jul 20, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd., Other Affiliate Teva Limited for Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (ceg) |
| Jul 20, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Adare Pharma US, Inc. for Adare Pharmaceuticals, Inc. filed by Adare Pharmaceuticals, Inc. (ceg) |
| Jul 20, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,399,025 B2; US 9,375,410 B2. (ceg) |
| Jul 20, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/7/2018. Date of Expiration of Patent: 11/14/2023.Thirty Month Stay Deadline: 12/7/2020. (ceg) |
| Jul 20, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Jul 20, 2018 | 1 | Civil Cover Sheet (2) |
| Jul 20, 2018 | 1 | Exhibit B (17) |
| Jul 20, 2018 | 1 | Main Document (20) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Inventia Healthcare Private Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2423623.) - filed by Teva Pharmaceuticals International GmbH, Adare Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(ceg) |
| Jul 20, 2018 | 1 | Exhibit A (17) |
| Jul 20, 2018 | 1 | Complaint* (1) |
